The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Natural history of multiple sclerosis: a unifying concept
Abstract
Multiple sclerosis can follow very different patterns of evolution and variable rates of disability accumulation. This raises the issue whether it represents one or several distinct diseases. We assessed demographic and clinical characteristics in 1844 patients with multiple sclerosis that we categorized according to the classification of Lublin and Reingold (1996) into 1066 (58%) relapsing-remitting, 496 (27%) secondary progressive, 109 (6%) progressive relapsing and 173 (9%) primary progressive cases of multiple sclerosis. Relapsing-remitting and secondary progressive cases shared similar age at disease onset (median = 28.7 versus 29.5 years; P = 0.21), initial symptoms of the relapsing-remitting phase, degree of recovery from the first neurological episode, and time from the first to the second episode. By contrast, disease duration was twice as long in secondary progressive than in relapsing-remitting cases (mean +/- SD = 17.6 +/- 9.6 versus 8.7 +/- 8.6 years; P < 0.001). Progressive relapsing and primary progressive cases were essentially similar in their clinical characteristics. In patients experiencing a progressive course, median age at onset of progressive phase was similar in secondary progressive cases and in cases who were progressive from onset (39.1 versus 40.1 years; P = 0.47). The proportion of cases with superimposed relapses during progression was approximately 40% in both categories. Finally, the 1562 patients with an exacerbating-remitting initial course and the 282 patients with a progressive initial course of the disease were essentially similar with respect to the time course of disability accumulation from assignment to a given disability score, and the age at assignment of disability landmarks. These observational data suggest that the clinical phenotype and course of multiple sclerosis are age dependent. Relapsing-remitting disease can be regarded as multiple sclerosis in which insufficient time has elapsed for the conversion to secondary progression; secondary progressive forms as relapsing-remitting multiple sclerosis that has 'grown older'; and progressive from onset cases as multiple sclerosis 'amputated' from the usual preceding relapsing-remitting phase. Times to reach disability milestones, and ages at which these landmarks are reached, follow a predefined schedule not obviously influenced by relapses, whenever they may occur, or by the initial course of the disease, whatever its phenotype. This leads to a unifying concept of the disease in which primary and secondary progression might be regarded as essentially similar. From the clinical and statistical positions, multiple sclerosis might be considered as one disease with different clinical phenotypes rather than an entity encompassing several distinct diseases-the position of complexity rather than true heterogeneity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
Kurtzke, J. F. (1983) · Neurology · doi:10.1212/wnl.33.11.1444 · Cited by 15,011
New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
Poser, C. M., Paty, D. W., Scheinberg, L., McDonald, W. I., Davis, F. A., Ebers, G. C., Johnson, K. P., Sibley, W. A., Silberberg, D. H., & Tourtellotte, W. W. (1983) · Annals of Neurology · doi:10.1002/ana.410130302 · Cited by 7,384
Defining the clinical course of multiple sclerosis: Results of an international survey
Lublin, F. D., Reingold, S. C., & National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis* (1996) · Neurology · doi:10.1212/wnl.46.4.907 · Cited by 3,686
Schumacher, G. A., Beebe, G., Kibler, R. F., Kurland, L. T., Kurtzke, J. F., McDowell, F., Nagler, B., Sibley, W. A., Tourtellotte, W. W., & Willmon, T. L. (1965) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1965.tb20235.x · Cited by 1,438
Relapses and Progression of Disability in Multiple Sclerosis
Confavreux, C., Vukusic, S., Moreau, T., & Adeleine, P. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011163432001 · Cited by 1,309
Self-citationThe natural history of multiple sclerosis:a geographically based study
Cottrell, D. A., Kremenchutzky, M., Rice, G. P. A., Koopman, W. J., Hader, W., Baskerville, J., & Ebers, G. C. (1999) · Brain · doi:10.1093/brain/122.4.625 · Cited by 1,163
Confavreux, C. (2003) · Brain · doi:10.1093/brain/awg081 · Cited by 996
Self-citationUse of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS
Rudick, R. A., Fisher, E., Lee, J.-C., Simon, J., Jacobs, L., & the Multiple Sclerosis Collaborative Research Group (1999) · Neurology · doi:10.1212/wnl.53.8.1698 · Cited by 736
Losseff, N. A., Webb, S. L., O'Riordan, J. I., Page, R., Wang, L., Barker, G. J., Tofts, P. S., McDonald, W. I., Miller, D. H., & Thompson, A. J. (1996) · Brain · doi:10.1093/brain/119.3.701 · Cited by 643
Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up
Runmarker, B., & Andersen, O. (1993) · Brain · doi:10.1093/brain/116.1.117 · Cited by 568
Age at disability milestones in multiple sclerosis
Confavreux, C., & Vukusic, S. (2006) · Brain · doi:10.1093/brain/awh714 · Cited by 525
Self-citationPrimary progressive multiple sclerosis
Thompson, A. (1997) · Brain · doi:10.1093/brain/120.6.1085 · Cited by 506
CONFAVREUX, C., AIMARD, G., & DEVIC, M. (1980) · Brain · doi:10.1093/brain/103.2.281 · Cited by 494
Self-citationMajor differences in the dynamics of primary and secondary progressive multiple sclerosis
Thompson, A. J., Kermode, A. G., Wicks, D., MacManus, D. G., Kendall, B. E., Kingsley, D. P. E., & McDonald, W. I. (1991) · Annals of Neurology · doi:10.1002/ana.410290111 · Cited by 486
Imaging axonal damage of normal-appearing white matter in multiple sclerosis
Fu, L. (1998) · Brain · doi:10.1093/brain/121.1.103 · Cited by 481
Progressive cerebral atrophy in multiple sclerosis A serial MRI study
Losseff, N. A., Wang, L., Lai, H. M., Yoo, D. S., Gawne-Cain, M. L., McDonald, W. I., Miller, D. H., & Thompson, A. J. (1996) · Brain · doi:10.1093/brain/119.6.2009 · Cited by 479
Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis
Filippi, M. (2003) · Brain · doi:10.1093/brain/awg038 · Cited by 371
Investigation of MS normal-appearing brain using diffusion tensor MRI with clinical correlations
Ciccarelli, O., Werring, D. J., Wheeler–Kingshott, C. A. M., Barker, G. J., Parker, G. J. M., Thompson, A. J., & Miller, D. H. (2001) · Neurology · doi:10.1212/wnl.56.7.926 · Cited by 349
On the evaluation of disability in multiple sclerosis
Kurtzke, J. F. (1961) · Neurology · doi:10.1212/wnl.11.8.686 · Cited by 330
EDMUS, a European database for multiple sclerosis.
Confavreux, C., Compston, D. A., Hommes, O. R., McDonald, W. I., & Thompson, A. J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.8.671 · Cited by 313
Self-citationYOUL, B. D., TURANO, G., MILLER, D. H., TOWELL, A. D., MACMANUS, D. G., MOORE, S. G., JONES, S. J., BARRETT, G., KENDALL, B. E., MOSELEY, I. F., et al. (1991) · Brain · doi:10.1093/brain/114.6.2437 · Cited by 259
Filippi, M., Rovaris, M., Inglese, M., Barkhof, F., De Stefano, N., Smith, S., & Comi, G. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17271-1 · Cited by 251
Some Aspects of the Natural History of Disseminated Sclerosis
(2015) · QJM: An International Journal of Medicine · doi:10.1093/qjmed/21.2.135 · Cited by 237
Progressive cerebral atrophy in MS: A serial study using registered, volumetric MRI
Fox, N. C., Jenkins, R., Leary, S. M., Stevenson, V. L., Losseff, N. A., Crum, W. R., Harvey, R. J., Rossor, M. N., Miller, D. H., & Thompson, A. J. (2000) · Neurology · doi:10.1212/wnl.54.4.807 · Cited by 225
Eriksson, M., Andersen, O., & Runmarker, B. (2003) · Multiple Sclerosis Journal · doi:10.1191/1352458503ms914oa · Cited by 221
The natural history of multiple sclerosis: a geographically based study
Kremenchutzky, M., Cottrell, D., Rice, G., Hader, W., Baskerville, J., Koopman, W., & Ebers, G. C. (1999) · Brain · doi:10.1093/brain/122.10.1941 · Cited by 186
Detection of ventricular enlargement in patients at the earliest clinical stage of MS
Brex, P. A., Jenkins, R., Fox, N. C., Crum, W. R., O’Riordan, J. I., Plant, G. T., & Miller, D. H. (2000) · Neurology · doi:10.1212/wnl.54.8.1689 · Cited by 185
Myhr, K., Riise, T., Vedeler, C. A., Nortvedt, M. W., Grønning, M., Midgard, R., & Nyland, H. (2001) · Multiple Sclerosis Journal · doi:10.1177/135245850100700110 · Cited by 184
A magnetization transfer histogram study of normal-appearing brain tissue in MS
Tortorella, C., Viti, B., Bozzali, M., Sormani, M. P., Rizzo, G., Gilardi, M. F., Comi, G., & Filippi, M. (2000) · Neurology · doi:10.1212/wnl.54.1.186 · Cited by 181
Primary and transitional progressive MS: A clinical and MRI cross-sectional study
Stevenson, V. L., Miller, D. H., Rovaris, M., Barkhof, F., Brochet, B., Dousset, V., Dousset, V., Filippi, M., Montalban, X., Polman, C. H., et al. (1999) · Neurology · doi:10.1212/wnl.52.4.839 · Cited by 177
The natural history of multiple sclerosis
Confavreux, C., & Compston, A. (2006) · McAlpine's Multiple Sclerosis · doi:10.1016/b978-0-443-07271-0.50006-9 · Cited by 166
Self-citationPrimary progressive multiple sclerosis: a 5-year clinical and MR study
Ingle, G. T. (2003) · Brain · doi:10.1093/brain/awg261 · Cited by 127
Course and prognosis of chronic progressive multiple sclerosis: Results of an epidemiological study
Minderhoud, J. M., van der Hoeven, J. H., & Prange, A. J. A. (1988) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1988.tb03611.x · Cited by 126
Vukusic, S., & Confavreux, C. (2003) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00426-4 · Cited by 126
Self-citationPatzold, U., & Pocklington, P. R. (1982) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1982.tb03084.x · Cited by 121
One year follow up study of primary and transitional progressive multiple sclerosis
Stevenson, V. L. (2000) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.68.6.713 · Cited by 113
A prospective study on the prognosis of multiple sclerosis
Amato, M. P., & Ponziani, G. (2000) · Neurological Sciences · doi:10.1007/s100720070021 · Cited by 108
Clinical study of primary progressive multiple sclerosis in Northern Ireland, UK
McDonnell, G. V., & Hawkins, S. A. (1998) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.64.4.451 · Cited by 101
Insulin Secretion and Acetylcholinesterase Activity in Monosodium L-Glutamate-Induced Obese Mice
Balbo, S. L., Gravena, C., Bonfleur, M. L., & Mathias, P. C. D. F. (2000) · Hormone Research in Paediatrics · doi:10.1159/000053257 · Cited by 88
Clinical studies on multiple sclerosis
Broman, T., Andersen, O., & Bergmann, L. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1981.tb00745.x · Cited by 84
Clinical concordance in sibling pairs with multiple sclerosis
Robertson, N. P., Clayton, D. G., Fraser, M., et al. (1996) · Neurology · doi:10.1212/wnl.47.2.347 · Cited by 82
Normal-appearing brain tissue MTR histograms in clinically isolated syndromes suggestive of MS
Traboulsee, A. L., Dehmeshki, J., Brex, P., Dalton, C. M., Chard, D., Barker, G. J., Plant, G. T., & Miller, D. (2002) · Neurology · doi:10.1212/wnl.59.1.126 · Cited by 80
Magnetic resonance spectroscopy: imaging axonal damage in MS
Arnold, D. L. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00074-0 · Cited by 74
The course of multiple sclerosis in 73 cases with computer-designed curves.
Fog, T., & Linnemann, F. (1970) · PubMed · Cited by 73
A comparison of sporadic and familial multiple sclerosis
Weinshenker, B. G., Bulman, D. E., Carriere, W., Baskerville, J., & Ebers, G. C. (1990) · Neurology · doi:10.1212/wnl.40.9.1354 · Cited by 65
Natural history of multiple sclerosis: implications for counselling and therapy
Confavreux, C., & Vukusic, S. (2002) · Current Opinion in Neurology · doi:10.1097/00019052-200206000-00006 · Cited by 49
Self-citationTransitional progressive multiple sclerosis: a clinical and imaging study
Gayou, A., Brochet, B., & Dousset, V. (1997) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.63.3.396 · Cited by 38
Multiple sclerosis: an ańalysis of 812 cases by means of electronic data processing.
Poser, S. (1978) · PubMed · Cited by 35
Primary progressive multiple sclerosis: a distinct syndrome?
McDonnell, G. V., & Hawkins, S. (1996) · Multiple Sclerosis Journal · doi:10.1177/135245859600200304 · Cited by 32
Progressive forms of MS: classification streamlined or consensus overturned?
Weinshenker, B. G. (2000) · The Lancet · doi:10.1016/s0140-6736(99)00356-6 · Cited by 23
Diagnostic criteria for primary progressive mutiple sclerosis: a position paper.
(2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200006)47:6 · Cited by 2
Cann, S. A. H., Netten, J. P. V., & Netten, C. V. (2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200003)47:3
Research works printed but not linked: 4
- Andersson PB, Waubant E, Gee L, Goodkin DE. Multiple sclerosis that is progressive from the time of onset. Clinical characteristics and progression of disability. Arch Neurol1999; 56: 1138–42. · doi:10.1001/archneur.56.9.1138
- Evangelou N, Esiri MM, Smith S, Palace J, Matthews PM. Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis. Ann Neurol2000; 47: 391–5. · doi:10.1002/1531-8249(200003)47:3<391::aid-ana20>3.0.co;2-j
- Filippi M, Campi A, Martinelli V, Pereira C, Scotti G, Comi G. Transitional progressive multiple sclerosis: MRI and MTI findings. Acta Neurol Scand1995; 92: 178–82. · doi:10.1111/j.1600-0404.1995.tb01036.x
- Lucchinetti C, Brück W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol2000; 47: 707–17. · DOI
Cited by
Defining the clinical course of multiple sclerosis: The 2013 revisions
Lublin, F. D., Reingold, S. C., Cohen, J. A., Cutter, G. R., Sørensen, P. S., Thompson, A. J., Wolinsky, J. S., Balcer, L. J., Banwell, B., Barkhof, F., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000560 · Cited by 3,177
Multiple Sclerosis: An Immune or Neurodegenerative Disorder?
Trapp, B. D., & Nave, K.-A. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.30.051606.094313 · Cited by 1,724
Multiple Sclerosis: Current Knowledge and Future Outlook
Kamm, C. P., Uitdehaag, B. M., & Polman, C. H. (2014) · European Neurology · doi:10.1159/000360528 · Cited by 1,010
Treatment of Multiple Sclerosis: A Review
Hauser, S. L., & Cree, B. A. C. (2020) · The American Journal of Medicine · doi:10.1016/j.amjmed.2020.05.049 · Cited by 969
“2020;383(6):546–557 [PubMed: 32757523] 28.”
Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis
Howell, O. W., Reeves, C. A., Nicholas, R., Carassiti, D., Radotra, B., Gentleman, S. M., Serafini, B., Aloisi, F., Roncaroli, F., Magliozzi, R., et al. (2011) · Brain · doi:10.1093/brain/awr182 · Cited by 858
Metadata
- Authors
- Confavreux, C., & Vukusic, S.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-01-16
- Volume
- 129
- Issue
- 3
- Pages
- 606-616
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2148563799
- Cited by
- 905
- References
- 52
- FWCI
- 21.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.